179 related articles for article (PubMed ID: 37187336)
1. The battle against fungi: lessons in antifungal stewardship from COVID 19 times.
Kanj SS; Haddad SF; Meis JF; Verweij PE; Voss A; Rautemaa-Richardson R; Levy-Hara G; Chowdhary A; Ghafur A; Brüggemann R; Bal AM; Schouten J
Int J Antimicrob Agents; 2023 Jul; 62(1):106846. PubMed ID: 37187336
[TBL] [Abstract][Full Text] [Related]
2. Fungal colonization and infections in patients with COVID-19 in intensive care units: A real-life experience at a tertiary-care hospital.
Avkan-Oğuz V; Çelİk M; Eren-Kutsoylu OÖ; Nazli A; Uğur YL; Taylan A; Ergan B; Irmak Ç; Duğral E; Özkütük AA
Respir Med Res; 2022 Nov; 82():100937. PubMed ID: 35792466
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.
Huang SF; Ying-Jung Wu A; Shin-Jung Lee S; Huang YS; Lee CY; Yang TL; Wang HW; Chen HJ; Chen YC; Ho TS; Kuo CF; Lin YT;
J Microbiol Immunol Infect; 2023 Jun; 56(3):442-454. PubMed ID: 36586744
[TBL] [Abstract][Full Text] [Related]
4. Fungal pathogens and COVID-19.
Singh A; Kaur A; Chowdhary A
Curr Opin Microbiol; 2023 Oct; 75():102365. PubMed ID: 37625261
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, risk factors, treatment and outcome of multidrug resistance Candida auris infections in Coronavirus disease (COVID-19) patients: A systematic review.
Vinayagamoorthy K; Pentapati KC; Prakash H
Mycoses; 2022 Jun; 65(6):613-624. PubMed ID: 35441748
[TBL] [Abstract][Full Text] [Related]
6. Determinants of fluconazole resistance and echinocandin tolerance in
Daneshnia F; de Almeida Júnior JN; Arastehfar A; Lombardi L; Shor E; Moreno L; Verena Mendes A; Goreth Barberino M; Thomaz Yamamoto D; Butler G; Perlin DS; Colombo AL
Emerg Microbes Infect; 2022 Dec; 11(1):2264-2274. PubMed ID: 36066554
[TBL] [Abstract][Full Text] [Related]
7. Antifungal stewardship with an emphasis on candidaemia.
Capoor MR; Subudhi CP; Collier A; Bal AM
J Glob Antimicrob Resist; 2019 Dec; 19():262-268. PubMed ID: 31195147
[TBL] [Abstract][Full Text] [Related]
8. Prevention of acquired invasive fungal infection with decontamination regimen in mechanically ventilated ICU patients: a pre/post observational study.
Massart N; Reizine F; Dupin C; Legay F; Legris E; Cady A; Rieul G; Barbarot N; Magahlaes E; Fillatre P
Infect Dis (Lond); 2023 Apr; 55(4):263-271. PubMed ID: 36694427
[TBL] [Abstract][Full Text] [Related]
9. The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.
Borman AM; Fraser M; Patterson Z; McLachlan S; Palmer MD; Mann C; Oliver D; Brown P; Linton CJ; Dzietczyk A; Hedley M; Gough M; Johnson EM
Med Mycol; 2021 Nov; 59(11):1068-1075. PubMed ID: 34259872
[TBL] [Abstract][Full Text] [Related]
10. Opportunistic
Altinkaya Çavuş M; Sav H
Pol J Microbiol; 2022 Sep; 71(3):411-419. PubMed ID: 36185025
[TBL] [Abstract][Full Text] [Related]
11. The first case of clade I Candida auris candidemia in a patient with COVID-19 in Japan.
Ohashi Y; Matono T; Suzuki S; Yoshino S; Alshahni MM; Komori A; Makimura K
J Infect Chemother; 2023 Jul; 29(7):713-717. PubMed ID: 37001753
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and Plethora of Fungal Infections.
Kundu R; Singla N
Curr Fungal Infect Rep; 2022; 16(2):47-54. PubMed ID: 35432691
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap.
Crone CG; Helweg-Larsen J; Steensen M; Arendrup MC; Helleberg M
J Mycol Med; 2022 Mar; 32(1):101228. PubMed ID: 34826672
[TBL] [Abstract][Full Text] [Related]
14. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
15. Coinfection of fungi with SARS-CoV-2 is a detrimental health risk for COVID-19 patients.
Baten N; Wajed S; Talukder A; Masum MHU; Rahman MM
Beni Suef Univ J Basic Appl Sci; 2022; 11(1):64. PubMed ID: 35529527
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and Candida duobushaemulonii superinfection: A case report.
Awada B; Alam W; Chalfoun M; Araj G; Bizri AR
J Mycol Med; 2021 Sep; 31(3):101168. PubMed ID: 34186378
[TBL] [Abstract][Full Text] [Related]
17. Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention.
Suleyman G; Alangaden GJ
Infect Dis Clin North Am; 2021 Dec; 35(4):1027-1053. PubMed ID: 34752219
[TBL] [Abstract][Full Text] [Related]
18. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
[TBL] [Abstract][Full Text] [Related]
19. Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes.
Chiurlo M; Mastrangelo A; Ripa M; Scarpellini P
New Microbiol; 2021 Apr; 44(2):71-83. PubMed ID: 34240742
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and outcomes of fungal superinfections in patients with severe COVID-19: an observational study from Pisa academic hospital.
Tiseo G; Galfo V; Occhineri S; Forniti A; Caroselli C; Falcone M; Menichetti F
Infez Med; 2022; 31(1):55-61. PubMed ID: 36908395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
